Home-based subcutaneous immunoglobulin G replacement therapy under real-life conditions in children and adults with antibody deficiency

BACKGROUND: Subcutaneous immunoglobulin (SCIG) therapy is an alternative to intravenous immunoglobulin (IVIG) therapy. METHODS: We evaluated the efficacy and safety of the SCIG Vivaglobin(® )(formerly known as Beriglobin(® )SC) under real-life conditions in a post-marketing observational study in 82...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffmann, F, Grimbacher, B, Thiel, J, Peter, HH, Belohradsky, BH
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351992/
https://www.ncbi.nlm.nih.gov/pubmed/20696632
http://dx.doi.org/10.1186/2047-783X-15-6-238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351992/
https://www.ncbi.nlm.nih.gov/pubmed/20696632
http://dx.doi.org/10.1186/2047-783X-15-6-238

Ejemplares similares